With coronavirus cases increasing to levels not seen since the summer, the Trump administration's plans to contain the spread are unclear. Pfizer won’t be ready to seek emergency approval for a COVID-19 vaccine until mid-November. And early testing programs in New York City schools are showing low case numbers.
Hosted on Acast. See acast.com/privacy for more information.
